鶹ýӰ

Handheld Device Detects Alzheimer's Biomarkers; Long COVID Smell Loss; MS Fatigue

— News and commentary from the world of neurology and neuroscience

MedpageToday
Neuro Break over a computer rendering of neurons.

A handheld wireless device using a graphene field-effect transistor sensor amyloid beta, tau, and alpha-synuclein. (Proceedings of the National Academy of Sciences)

Whistleblowers suggested that a University of Southern California neuroscientist that supported a major stroke trial and blood-brain barrier research. (Science)

Loss of over 3 years in long COVID patients who had mild acute SARS-CoV-2 infection. (JAMA Otolaryngology-Head and Neck Surgery)

A pragmatic trial showed that people with Parkinson's disease and related disorders who had a reported better quality of life at 6 months and were more likely to complete advance directives. (JAMA Neurology)

A in multiple sclerosis (MS), a small trial showed. (Multiple Sclerosis Journal)

Blood-based biomarkers in primary progressive MS. (Journal of Neurology, Neurosurgery, and Psychiatry)

Molecular biomarkers have been linked to but none are used clinically, a review showed. (Nature Reviews Neurology)

The autism-linked gene SYNGAP1 of human brain development. (Nature Neuroscience)

Boston University's Ann McKee, MD, is on a mission to save brains from (CTE) by making contact sports safer. (Wired)

"Seinfeld" episodes between a brain region that helped people enjoy a joke and another that helped them get it. (Journal of Neuroscience)

  • Judy George covers neurology and neuroscience news for MedPage Today, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more.